PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsHaemophilus infections
MeSH D006192 - haemophilus infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D016871:Pasteurellaceae infections
0 Companies
0 Drugs
Success rate
D006192: 
Haemophilus infections
D002602:Chancroid
D008583:Haemophilus meningitis
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAmoxicillin, Clavulanic acid Amoxicillin Clavulanate Potassium  2004-05-25   
Levofloxacin Levofloxacin  2011-06-20   
Ofloxacin Ofloxacin  2003-09-02   
Glenmark PharmaceuticalsLevofloxacin Levofloxacin  2011-06-20   
MylanLevofloxacin Levofloxacin  2011-06-20   
Rifampin Rifampin  2008-05-22   
Rising PharmaceuticalsAmoxicillin, Lansoprazole, Clarithromycin Lansoprazole, Amoxicillin Clarithromycin  2016-10-07   
Levofloxacin Levofloxacin  2010-12-20   
NATCO PharmaLevofloxacin Levofloxacin  2011-06-20   
Johnson & JohnsonOfloxacin Floxin  1990-12-28   
Levofloxacin Levaquin  1996-12-20   
GSKTicarcillin, Clavulanic acid Timentin  1986-12-19   
Lupin ResearchLevofloxacin Levofloxacin  2011-06-20   
Rifampin Rifampin  2013-08-21   
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
100%
43/43
Approved: 43Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Mylan
1
2
3
4
5
6
...
10
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use